Irritants - CS, CN, CNC, CA, CR, CNB, PS 

  • Author: Paul P Rega, MD, FACEP; Chief Editor: Robert G Darling, MD, FACEP   more...
 
Updated: Aug 29, 2011
 

Background

The sole purpose of irritants, also known as tear gas, riot control agents, and lachrymators, is to produce immediate discomfort and eye closure to render the victim incapable of fighting or resisting. Police forces use them for crowd control, and military forces currently use them mainly for training. They were used before World War I, and, during the war, they were the first chemical agents used—well before the better-known chlorine, phosgene, and mustard gas. The United States used them during the Vietnam War to deny tunnel access to its enemies. The United States excludes these agents from the 1925 Geneva Convention banning other chemical and biological weapons. Dispersal is allowed in specific US military operations but only by presidential order.

Tear gas (CS) and chloroacetophenone (CN) are by far the most important pulmonary irritants. These types of compounds were assigned these 2-letter codes by The North Atlantic Treaty Organization (NATO). CN was the primary pulmonary irritant after World War I until Corson and Stoughton developed CS in 1928. CS was found to be more potent (10 times more potent as a lachrymator than CN) but less toxic. In approximately 1959, CS replaced CN as the principal military and law enforcement riot control agent. CS gas is the familiar tear gas most often used by police for crowd control (eg, the police in the United Kingdom have used CS as an incapacitant for the past decade). CN is available as Mace, an over-the-counter product used for personal protection. Capsaicin, or pepper spray, has to some extent replaced CN as a personal protective agent, with less dangerous effects.

Although CS and CN are the most important agents in this class, several others require mention. Chloropicrin (PS) and bromobenzenecyanide (CA) were developed before World War I. Both largely have been replaced, as they were too lethal for their intended effects but not lethal enough to compete with the more effective blistering and nerve agents. PS is still seen occasionally as a soil sterilant or grain disinfectant. The creation of CNB (CN, carbon tetrachloride, and benzene), chloroacetophenone in chloroform (CNC), and CNS (CN, chloroform, and PS) attempted to make CN more effective. However, CS proved more effective and less toxic than any of the CN series and largely has replaced them.

Dibenz-(b,f)-1,4-oxazepine (CR) is a more recent tear gas, first synthesized in 1962. It reportedly is more potent and less toxic than CS. Part of its high safety profile is due to its low volatility, which minimizes its effects deep in the pulmonary system. However, it is still is not used widely. Pepper spray, or oleoresin capsicum (OC), is also considered a riot control agent. A 1% solution is sold commercially to the public, but solutions exist that have a 10% concentration. OC causes the release of a neuropeptide (substance P) that causes pain and inflammation.

The possibility of secondary contamination is very real. Recently, CS was used to flush out possible stowaways on a cargo vehicle. When the cargo was finally delivered to 16 stores within Scotland, 21 workers experienced itching and running eyes, rhinorrhea, a burning sensation on the face and hands, and a burning throat.[1]

Next

Pathophysiology

Riot control agents are solids with low vapor pressures that are dispersed as fine particles or in solution. CS and CN are SN2 alkylating agents and react at nucleophilic sites. Although presently unclear, injuries caused by this class of agents may be caused by inactivation of sulfhydryl-containing enzymes such as lactic dehydrogenase and a specific coenzyme in the pyruvate decarboxylase system (disulfhydryl form of lipoic acid).

Recent research has indicated that these agents are extremely potent activators of the body's TRPA1 (a family of transient receptor potential ion channel) receptors (ie, mechanical stress sensors).[2]

Previous
 
 
Contributor Information and Disclosures
Author

Paul P Rega, MD, FACEP  Assistant Professor, Department of Public Health and Preventive Medicine, The University of Toledo College of Medicine; Assistant Professor, Department of Emergency Medicine, The University of Toledo College of Medicine; Director of Emergency Medicine Education and Disaster Management, OMNI Health Services

Paul P Rega, MD, FACEP is a member of the following medical societies: American College of Emergency Physicians and Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

Specialty Editor Board

Mark Keim, MD  Senior Science Advisor, Office of the Director, National Center for Environmental Health, Centers for Disease Control and Prevention

Mark Keim, MD is a member of the following medical societies: American College of Emergency Physicians

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD  Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

Rick Kulkarni, MD  Attending Physician, Department of Emergency Medicine, Cambridge Health Alliance, Division of Emergency Medicine, Harvard Medical School

Rick Kulkarni, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Emergency Medicine, American College of Emergency Physicians, American Medical Association, American Medical Informatics Association, Phi Beta Kappa, and Society for Academic Emergency Medicine

Disclosure: WebMD Salary Employment

John D Halamka, MD, MS  Associate Professor of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center; Chief Information Officer, CareGroup Healthcare System and Harvard Medical School; Attending Physician, Division of Emergency Medicine, Beth Israel Deaconess Medical Center

John D Halamka, MD, MS is a member of the following medical societies: American College of Emergency Physicians, American Medical Informatics Association, Phi Beta Kappa, and Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

Chief Editor

Robert G Darling, MD, FACEP  Adjunct Clinical Assistant Professor of Military and Emergency Medicine, Uniformed Services University of the Health Sciences, F Edward Hebert School of Medicine; Associate Director, Center for Disaster and Humanitarian Assistance Medicine

Robert G Darling, MD, FACEP is a member of the following medical societies: American College of Emergency Physicians, American Medical Association, American Telemedicine Association, and Association of Military Surgeons of the US

Disclosure: Nothing to disclose.

Acknowledgments

The authors and editors of eMedicine gratefully acknowledge the contributions of previous authors, Eric Mowatt-Larssen, MD, and David P Sole, DO, to the development and writing of this article.

References
  1. Hankin SM, Ramsay CN. Investigation of accidental secondary exposure to CS agent. Clin Toxicol (Phila). May 2007;45(4):409-11. [Medline].

  2. Brone B, Peeters PJ, Marrannes R, et al. Tear gasses CN, CR, and CS are potent activators of the human TRPA1 receptor. Toxicol Appl Pharmacol. Sep 2008;231(2):150-6. [Medline].

  3. Karagama YG, Newton JR, Newbegin CJ. Short-term and long-term physical effects of exposure to CS spray. J R Soc Med. Apr 2003;96(4):172-4. [Medline].

  4. Watson K, Rycroft R. Unintended cutaneous reactions to CS spray. Contact Dermatitis. Jul 2005;53(1):9-13. [Medline].

  5. Billmire DF, Vinocur C, Ginda M, Robinson NB, Panitch H, Friss H. Pepper-spray-induced respiratory failure treated with extracorporeal membrane oxygenation. Pediatrics. Nov 1996;98(5):961-3. [Medline].

  6. Sam Shen. Riot-control agent attack. In: Ciottone GR, Anderson PD, Auf Der Heide E, Darling RG, Jacoby I, Noji E, Suner S, eds. Disaster Medicine. 3rd ed. Philadelphia, PA: Mosby/Elsevier; 2006:Chap 98, 593-595.

  7. Centers for Disease Control and Prevention. Riot Control Agent Poisoning. CDC: Emergency Preparedness and Response. Available at http://emergency.cdc.gov/agent/riotcontrol/agentpoisoning.asp. Accessed March 7, 2009.

  8. Viala B, Blomet J, Mathieu L, Hall AH. Prevention of CS "tear gas" eye and skin effects and active decontamination with Diphoterine: preliminary studies in 5 French Gendarmes. J Emerg Med. Jul 2005;29(1):5-8. [Medline].

  9. Army, Marine Corps, Navy, Air Force. Military Chemical Compounds and Their Properties in Potential Military Chemical/Biological Agents and Compounds. January 2005. Available at www.mipt.org/pdf/Potential-Military-Chemical-Biological-Agents-Compounds.pdf. Accessed April 2, 2005.

  10. Bentur Y, Gomez J. Incapacitating agents: BZ, calmative agents, and riot control agents. In: Keyes DC, Burstein JL, Schwartz RB, et al, eds. Medical Response to Terrorism, Preparedness and Clinical Practice. Philadelphia, PA: Lippincott Williams & Wilkins; 2005.

  11. Blain PG. Tear gases and irritant incapacitants. 1-chloroacetophenone, 2-chlorobenzylidene malononitrile and dibenz[b,f]-1,4-oxazepine. Toxicol Rev. 2003;22(2):103-10. [Medline].

  12. CDC. Brief report: exposure to tear gas from a theft-deterrent device on a safe--Wisconsin, December 2003. MMWR Morb Mortal Wkly Rep. Mar 5 2004;53(8):176-7. [Medline].

  13. CDC. Riot Control Agent Poisoning. Centers for Disease Control and Prevention Web site. Available at www.bt.cdc.gov/agent/riotcontrol/agentpoisoning.asp. Accessed May 12, 2004.

  14. Chemical Casualty Care Division USAMRICD. Medical Response to Chemical Warfare and Terrorism. 3rd ed. i-iv, 73-79.

  15. Compton JA. Tear agents. In: Military Chemical and Biological Agents. 1987:208-252.

  16. Field Manual. Riot Control Agents. Treatment of Chemical Agent Casualties and Convention Military Chemical Injuries. Medical NBC Online Web site. Available at www.nbc-med.org/SiteContent/MedRef/OnlineRef/FieldManuals/fm8_285/Part_2/chapter7.htm. Accessed April 2, 2005.

  17. Lillie SH, Hanlon E, Kelly JM, eds. Potential Military Chemical/Biological Agents and Compounds (FM3-11.9). 2005.

  18. Nelson LS. Simple asphyxiants and pulmonary irritants. In: Goldfrank LR, Flomenbau NE, Lewin NA, eds. Goldfrank's Toxicologic Emergencies. Appleton & Lange; 1998:1523-1538.

  19. Sidell FR. Riot control agents. In: Textbook of Military Medicine. Part 1. 1997:307-324.

  20. USAMRICD. Riot Control Agents in Medical Management of Chemical Casualties Handbook. 3rd ed. USAMRICD. Available at: https://ccc.apgea.army.mil/sarea/products/handbooks/MMCC/mmccthirdeditionjul2000.pdf. July 2000.

  21. Weir E. The health impact of crowd-control agents. CMAJ. Jun 26 2001;164(13):1889-90. [Medline].

Previous
Next
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.